Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
European Urology Oncology
|
May 3, 2021
Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guérin Therapy Outcomes
Patrick J Hensley, Kelly K Bree, Nathan Brooks, et al.
The Journal of Urology
|
June 30, 2022
Reply by Authors
Kelly K Bree, Patrick J Hensley, Niyati Lobo, et al.
BJU International
|
January 23, 2021
Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer
Kelly K Bree, Patrick J Hensley, Nathan A Brooks, et al.
European Urology Oncology
|
February 1, 2024
Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?
Niyati Lobo, Zhigang Duan, Akshay Sood, et al.
The Journal of Urology
|
June 29, 2021
Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy
Patrick J Hensley, Kelly K Bree, Matthew T Campbell, et al.
The Journal of Urology
|
August 10, 2021
Reply by Authors
Patrick J Hensley, Kelly K Bree, Matthew T Campbell, et al.
The Journal of Urology
|
November 3, 2023
Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience
Akshay Sood, Jan K Rudzinski, Craig V Labbate, et al.
European Urology Oncology
|
June 3, 2026
Survival Outcomes of a Smoking Cessation Treatment Program After Diagnosis of Bladder Cancer
Landan P MacDonald, George Kypriotakis, Maher Karam-Hage, et al.
European Urology
|
October 4, 2025
Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the Bladder
Amanda A Myers, Ruchika Talwar, Zhigang Duan, et al.
European Urology Oncology
|
October 11, 2025
Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group
Roger Li, Patrick J Hensley, Marko Babjuk, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
European Urology Oncology
|
May 3, 2021
Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guérin Therapy Outcomes
Patrick J Hensley, Kelly K Bree, Nathan Brooks, et al.
The Journal of Urology
|
June 30, 2022
Reply by Authors
Kelly K Bree, Patrick J Hensley, Niyati Lobo, et al.
BJU International
|
January 23, 2021
Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer
Kelly K Bree, Patrick J Hensley, Nathan A Brooks, et al.
European Urology Oncology
|
February 1, 2024
Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?
Niyati Lobo, Zhigang Duan, Akshay Sood, et al.
The Journal of Urology
|
June 29, 2021
Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy
Patrick J Hensley, Kelly K Bree, Matthew T Campbell, et al.
The Journal of Urology
|
August 10, 2021
Reply by Authors
Patrick J Hensley, Kelly K Bree, Matthew T Campbell, et al.
The Journal of Urology
|
November 3, 2023
Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience
Akshay Sood, Jan K Rudzinski, Craig V Labbate, et al.
European Urology Oncology
|
June 3, 2026
Survival Outcomes of a Smoking Cessation Treatment Program After Diagnosis of Bladder Cancer
Landan P MacDonald, George Kypriotakis, Maher Karam-Hage, et al.
European Urology
|
October 4, 2025
Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the Bladder
Amanda A Myers, Ruchika Talwar, Zhigang Duan, et al.
European Urology Oncology
|
October 11, 2025
Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group
Roger Li, Patrick J Hensley, Marko Babjuk, et al.
Page
of 5